Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study

Yokota, K; Uchi, H; Uhara, H; Yoshikawa, S; Takenouchi, T; Inozume, T; Ozawa, K; Ihn, H; Fujisawa, Y; Qureshi, A; de Pril, V; Otsuka, Y; Weber, J; Yamazaki, N

Yokota, K (reprint author), Nagoya Univ Hosp, Dept Dermatol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.

JOURNAL OF DERMATOLOGY, 2019; 46 (12): 1197

Abstract

The multinational phase 3 CheckMate 238 trial compared adjuvant therapy with nivolumab versus ipilimumab among patients with resected stage III or IV ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索